SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-14-401032
Filing Date
2014-11-06
Accepted
2014-11-06 16:13:55
Documents
3
Period of Report
2014-10-27
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d814565d8ka.htm 8-K/A 17981
2 EX-2.1 d814565dex21.htm EX-2.1 165475
3 EX-10.3 d814565dex103.htm EX-10.3 113528
  Complete submission text file 0001193125-14-401032.txt   298147
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12465 | Film No.: 141200834
SIC: 2834 Pharmaceutical Preparations